Septerna

Septerna is a clinical-stage biotechnology company focused on discovering and developing oral small-molecule therapies for GPCR targets. Its pipeline spans endocrinology, immunology and inflammation, and metabolic diseases, supported by its proprietary Native Complex Platform and collaboration revenue.

Relationship details are part of the Pro plan.